Aktuellt

Featured Image
Summary Palliative care should be offered together with disease-modifying therapies, to meet physical, psychosocial, social and spiritual needs. ERS SATELITTE 2026 COPD:...
28 mai 2026
 · 
3 min read
Featured Image
Addressing treatable traits important part of precision medicine in COPD Breakthroughs in COPD care are not always dramatic innovations but often consist...
28 mai 2026
 · 
5 min read
Featured Image
Sammendrag At this year’s ERS Satellite, Professor Surya Bhatt presented a compelling update on the evolving diagnostic paradigm in chronic obstructive pulmonary...
28 mai 2026
 · 
4 min read
Featured Image
Sammendrag The focus of COPD management should be shifted towards primary prevention, argues Professor Gappa, as a growing body of evidence points...
28 mai 2026
 · 
4 min read
Featured Image
Sammendrag House dust mite-induced allergic rhinitis affects approximately 40% of the global population and significantly impacts sleep, school performance, and work productivity....
28 mai 2026
 · 
3 min read
Featured Image
ERS satellite, March 2026ASTHMA A Patient-centred approach to understanding the spectrum of asthma management SpeakerProfessor António Jaime Correia De SousaMohamed Shamji, United...
17 mars 2026
 · 
4 min read
Featured Image
Sammendrag Occupational asthma can be caused by irritants or via sensitising, either IgE-mediated or unknown pathomechanisms. Identifying the source is key to...
17 mars 2026
 · 
3 min read
Chiesi Logo – 1. website_Primary_pant_RGB

Chiesi er et familieeid legemiddelselskap grunnlagt i 1935. Vi tror på innovasjon, ansvar og menneskelig empati. Vår lidenskap er å forbedre livskvaliteten for pasienter over hele verden gjennom forskning, utvikling og bærekraftige løsninger. 

© 2026 Chiesi Pharma AB. Dette nettstedet er beregnet på helsepersonell i Norge.